EcoDrugPlus

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSECRG00000021101
Gene Symbol: PSMA2
3 Cross references
287 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSECRG00000015974
Gene Symbol: PSMA3
3 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSECRG00000009052
Gene Symbol: PSMA3
1 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSECRG00000021960
Gene Symbol: PSMA4
3 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSECRG00000000820
Gene Symbol: PSMA5
3 Cross references
212 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSECRG00000014025
Gene Symbol: PSMA6
3 Cross references
308 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSECRG00000009862
Gene Symbol: PSMA7
3 Cross references
158 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSECRG00000004585
Gene Symbol: PSMA8
3 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSECRG00000003628
Gene Symbol: PSMB1
3 Cross references
219 Possible Orthologues:

Proteasome 20s Subunit Beta 11b

Ensembl ID : ENSECRG00000012282
Gene Symbol: PSMB11B
1 Cross references
228 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSECRG00000012592
Gene Symbol: PSMB2
3 Cross references
222 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSECRG00000021352
Gene Symbol: PSMB3
3 Cross references
261 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).